
“The quality and coverage of B2B contact database are very impressive...”
Mark J.
`
+12
The Subcutaneous Drug Development & Delivery Consortium (SC Consortium) aims to collaboratively transform patient care and improve patient outcomes by leading fundamental advancements in the SC drug development and delivery space, in a precompetitive manner. The SC Consortium is led by leaders in the SC industry, who focus on driving forward activities and efforts that allow participating organizations to provide value to the entire SC ecosystem. You can visit the website to learn more about our ongoing efforts, from workshops to data-pooling to manuscript development, and more! Our 2022 sub-team roadmaps are focused on 5 key areas fundamental to development...
Pharmaceutical,sc bioavailability,high dose,large volume,patient preferences,patient experiece,immunogenicity,clinical trials,sc product development,combination products,payer preferences,drug development,drug delivery,biologics,device,ddc,and sustainability
Subcutaneous drug development & delivery consortium operates in the Non-profit organizations industry.
Subcutaneous drug development & delivery consortium's revenue is 11m - 100m
Subcutaneous drug development & delivery consortium has 11 - 50 employees.
Get Started with the Free Forever plan! No credit card needed. Enjoy up to 10,000 free email credits per month at no cost.
Start Prospecting from Clodura.AI's database of 600M+ verified B2B contacts and 120M+ direct dials along with 18M+ companies' org charts.
Unlock the prospect's contact details, including verified email, direct dials, add them to cadence, and close more deals.